Published in EMBO Rep on November 13, 2012
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile. Cell Cycle (2014) 0.84
VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway. Tumour Biol (2016) 0.76
Perspective on the dynamics of cancer. Theor Biol Med Model (2017) 0.75
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
On respiratory impairment in cancer cells. Science (1956) 14.07
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res (2009) 6.74
Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab (2012) 3.81
Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov (2012) 3.03
Finding a Panacea among combination cancer therapies. Cancer Res (2011) 0.98
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell (2002) 8.38
Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci (2008) 4.32
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med (2011) 2.87
Three-dimensional analysis of a viral RNA replication complex reveals a virus-induced mini-organelle. PLoS Biol (2007) 2.85
Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol Cell (2008) 2.26
Transform-based backprojection for volume reconstruction of large format electron microscope tilt series. J Struct Biol (2006) 1.98
Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett (2006) 1.61
BUB1 mediation of caspase-independent mitotic death determines cell fate. J Cell Biol (2007) 1.52
A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A (2010) 1.51
Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy. PLoS One (2011) 1.18
The fractalkine/CX3CR1 system regulates β cell function and insulin secretion. Cell (2013) 1.16
Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa. Clin Transl Sci (2011) 1.08
Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis (2002) 1.06
Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2+ homeostasis. EMBO Mol Med (2013) 1.04
Finding a Panacea among combination cancer therapies. Cancer Res (2011) 0.98
A thermodynamic model describing the nature of the crista junction: a structural motif in the mitochondrion. J Struct Biol (2002) 0.98
Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1. Biochim Biophys Acta (2009) 0.96
An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small (2008) 0.86
Quantitative evaluation of the mitochondrial proteomes of Drosophila melanogaster adapted to extreme oxygen conditions. PLoS One (2013) 0.84
Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise. J Cardiovasc Pharmacol (2012) 0.84
Perturbations in skeletal muscle sarcomere structure in patients with heart failure and type 2 diabetes: restorative effects of (-)-epicatechin-rich cocoa. Clin Sci (Lond) (2013) 0.81
Clearing the brain's cobwebs: the role of autophagy in neuroprotection. Curr Neuropharmacol (2008) 0.80
Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial. Food Funct (2016) 0.75